ScreenerHero
EAHECO Animal Health Group plc
LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · ecoanimalhealth.com
101.00GBp0.00%Mkt Cap: 73.24M $P/E: 33.67

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respirat…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap73.24M $
Enterprise Value61.25M $
Revenue (TTM)95.14M $
Gross Profit46.19M $
Net Income (TTM)2.38M $
Revenue/Share1.416 USD
Last Price101.00 GBp
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees213
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINLU2356220926
Valuation
P/E (Trailing)33.67
P/E (Forward)21.18
PEG—
EV/EBITDA7.30
EV/Revenue0.64
P/S0.77
P/B0.78
EPS (TTM)0.03
EPS (Forward)0.05
52W Range
0.000086% of range116.90
52W High116.90 GBp
52W Low0.0000 GBp
Profitability
Gross Margin48.55%
Oper. Margin9.46%
EBITDA Margin8.82%
Profit Margin2.50%
ROE2.51%
ROA1.85%
Growth
Revenue Growth3.70%
Earnings Growth-24.50%
Cash Flow & Leverage
Operating CF8.32M $
CapEx (TTM)4.11M $
FCF Margin6.10%
FCF Yield7.92%
Net Debt-22.28M $
Net Debt/EBITDA-2.66
Balance Sheet
Debt/Equity0.06
Current Ratio3.42
Quick Ratio2.63
Book Value/Sh1.285 GBp
Cash/Share0.3750 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield2.45%
Payout Ratio0.00%
Ex-Div DateSep 23, 2021
Pay Date—
Splits
Last Split3:1
Split DateOct 18, 2002
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)202.00 GBp
Upside (mean)+100.0%
Target Range165.00 GBp – 273.00 GBp
GBp165.00+100.0% to meanGBp273.00
# Analysts5
Ownership
Shares Out.66.71M
Float59.27M
Insiders11.81%
Institutions69.63%
Technical
SMA 5093.07 (+8.5%)
SMA 20098.12 (+2.9%)
Beta0.00
S&P 52W Chg19.97%
Avg Vol (30d)182.49K
Avg Vol (10d)123.00K
Technical Indicators
RSI (14)61.2
MACD2.3317
MACD Signal2.1764
MACD Hist.+0.1553
BB Upper105.22 GBp
BB Middle98.20 GBp
BB Lower91.19 GBp
BB Width14.28%
ATR (14)4.247 GBp
Vol Ratio (20d)0.26x